Novartis Investigative Site

Nitra, Slovakia 950 01

0 studies enrolling now · 6 studies all time

What they study most

Acute Decompensated Heart Failure, Cardiovascular Disease, Congestive Heart Failure, Heart Failure, Heart Failure With Reduced Ejection Fraction, Relapsing Multiple Sclerosis, Systolic Hypertension, Type 2 Diabetes Mellitus

Studies at this site

• An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab — Completed
• A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure — Stopped early
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early
• Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure — Completed